Back to Search
JOHN LATZ, M.D.
M.D.
Psychiatry Physician
NPI: 1013972025IndividualAccepts Medicare
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
35688(NC)
Education
WAKE FOREST UNIVERSITY SCHOOL OF MEDICINE
Class of 1991
Research & Publications (16)
Pharmacokinetic evaluation of platinum derived from cisplatin administered alone and with pemetrexed in head and neck cancer patients.
PMID 19011858·Cancer Chemother Pharmacol·2009
3-trial
Population pharmacokinetic/pharmacodynamic analyses of pemetrexed and neutropenia: effect of vitamin supplementation and differences between Japanese and Western patients.
PMID 19118064·Clin Cancer Res·2009
4-observational
Phase I and pharmacokinetic study of pemetrexed plus cisplatin in chemonaive patients with locally advanced or metastatic malignant pleural mesothelioma or non-small cell lung cancer.
PMID 19118069·Clin Cancer Res·2009
3-trial
Phase I/II pharmacokinetic study of pemetrexed and epirubicin in patients with locally advanced or metastatic breast cancer.
PMID 18269776·Clin Breast Cancer·2007
3-trial
A phase I and pharmacokinetic study of pemetrexed plus irinotecan in patients with advanced solid malignancies.
PMID 17255275·Clin Cancer Res·2007
3-trial
Phase I and pharmacokinetic study of pemetrexed with high-dose folic acid supplementation or multivitamin supplementation in patients with locally advanced or metastatic cancer.
PMID 17473199·Clin Cancer Res·2007
3-trial
A semimechanistic-physiologic population pharmacokinetic/pharmacodynamic model for neutropenia following pemetrexed therapy.
PMID 16322990·Cancer Chemother Pharmacol·2006
8-other
Clinical application of a semimechanistic-physiologic population PK/PD model for neutropenia following pemetrexed therapy.
PMID 16322992·Cancer Chemother Pharmacol·2006
8-other
Two drug interaction studies evaluating the pharmacokinetics and toxicity of pemetrexed when coadministered with aspirin or Ibuprofen in patients with advanced cancer.
PMID 16428497·Clin Cancer Res·2006
4-observational
Population pharmacokinetic analysis of ten phase II clinical trials of pemetrexed in cancer patients.
PMID 16322991·Cancer Chemother Pharmacol·2006
8-other
A phase I study of pemetrexed (LY231514) supplemented with folate and vitamin B12 in Japanese patients with solid tumours.
PMID 16940981·Br J Cancer·2006
3-trial
A phase I study of pemetrexed (ALIMTA) and cyclophosphamide in patients with locally advanced or metastatic breast cancer.
PMID 17145830·Clin Cancer Res·2006
3-trial
Phase I and pharmacokinetic study of pemetrexed administered every 3 weeks to advanced cancer patients with normal and impaired renal function.
PMID 16391300·J Clin Oncol·2006
3-trial
A phase I/II study of pemetrexed and vinorelbine in patients with non-small cell lung cancer.
PMID 15923057·Lung Cancer·2005
3-trial
Phase I and pharmacokinetic study of the multitargeted antifolate pemetrexed in combination with oxaliplatin in patients with advanced solid tumors.
PMID 15205208·Ann Oncol·2004
3-trial
Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck.
PMID 11531245·Br J Cancer·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 106 4TH AVE SW
CATAWBA, NC 28609 - Phone
- (704) 662-3270
Quick Facts
- NPI
- 1013972025
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 35
- Publications
- 16
Are you this provider?
Claim Your Profile